Publications by authors named "Jinzhao Zhai"

Claim this Profile
P
PD-1/PD-L1 inhibitors monotherapy vs. combination therapy in elderly advanced NSCLC: a real-world study and nomogram for survival prognosis.
Yunye Mao, An Wang, Xiangwei Ge, Jinzhao Zhai, Yi Hu

BMC Pulm Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Comparative Study of the Efficacy and Safety of Immune Monotherapy versus 
Immunotheray Combined with Chemotherapy in Elderly Patients Aged 75 Years 
and Above with Advanced Non-small Cell Lung Cancer].
Yunye Mao, An Wang, Shu Sheng, Yangyang Jia, Xiangwei Ge, Jinzhao Zhai

Zhongguo Fei Ai Za Zhi· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current Status and Prospect of PD-1/PD-L1 Immune Checkpoint Inhibitor Therapy 
in Elderly Patients with Advanced NSCLC].
Yunye Mao, Shu Sheng, An Wang, Jinzhao Zhai, Xiangwei Ge

Zhongguo Fei Ai Za Zhi· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study.
Di Lu, Zhiqiang Ma, Di Huang, Jundong Zhang, Jinfeng Li, Jinzhao Zhai

Transl Lung Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: A Bayesian network meta-analysis of randomized controlled trials.
Jinzhao Zhai, Jiangyue Lu, Zhibo Zhang, Yuan Wang, Xiaoyan Li

Cancer Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis